BCL2L1 inhibitor A-1331852 inhibits MCL1 transcription and triggers apoptosis in acute myeloid leukemia cells. Chiou JT, Wu YY, Lee YC, Chang LS, et al. Biochem Pharmacol 2023;215:115738.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chiou JT, Wu YY, Lee YC, Chang LS, et al. BCL2L1 inhibitor A-1331852 inhibits MCL1 transcription and triggers apoptosis in acute myeloid leukemia cells. Biochem Pharmacol 2023;215:115738.
PMID: 37562509